Skip to content. | Skip to navigation

News
>
Article | Developing an Injectable Compound for a Dual-Chamber Delivery System

Article | Developing an Injectable Compound for a Dual-Chamber Delivery System

Medium: PharmTech.com
Author: Joerg Zimmermann

When considering whether to use a dual-chamber system for a lyophilized drug, it is important to understand the necessary development process.

As global demand for injectable systems grows, so too does the demand for innovative delivery options beyond the traditional system of syringe and vial. For lyophilized forms, dual-chamber systems offer advantages. The prefilled dual-chamber system or cartridge is self-contained, holding both the lyophilized product and diluent in separate chambers. As such, there are fewer reconstitution steps. And there is reduced overfill, which results in API savings. The predefined dosing also means greater safety for the patient and caregiver as well as ease of self-administration.

In this article Joerg Zimmermann talks about the necessary steps of a dual-chamber development process. 
 

Read the article "Developing an Injectable Compound for a Dual-Chamber Delivery System"

 

 


Related  articles


Vetter Answers:

Path to market in a dual-chamber system: differences in development with a dual-chamber system

Learn more


Vetter Packaging Solutions: 

Vetter systems: dual-chamber syringes and cartridges

Learn more


Lyophilization: Growing with Biotechnology

Technology that meets an increasing trend

Learn more


 

Back to newsroom